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ABSTRACT 
Objective: Hypertension today has a remained a focus in developing countries. This study aim was to determine the treatment adherence measured 
by the 8-item Morisky Medication Adherence Scale (MMAS-8) in hypertensive outpatients.  
Methods: A cross-sectional study was carried out with hypertensive patients older than 18 y, treated at eight of the primary health care in Special 
Region of Yogyakarta through interviews, between January and April 2016. Adherence was determined by MMAS-8 version translated for this study.  
Results: The patients consider low adherence (score<6), moderate adherence (score 6–7) and high adherence when they had a score equal to 8 at 
the MMAS-8. The prevalence of adherence among the 233 patients in primary health care showed the majority was lower adherence (57.90%), the 
moderate adherence (30.25%) and the high adherence (11.82%). The average adherence value according to the MMAS-8 was 5.2 (±1.7).  
Conclusion: Non-adherence treatments of hypertensive outpatients in primary health care was highest through application of MMAS-8  
Keywords: Adherence, MMAS, Hypertension, Primary health care 




Hypertension remains a considerable issue in every corner of the 
world. The increasing prevalence of hypertension in most countries is 
a special challenge against the risk of complication incidence, 
particularly in such vital organs as heart and kidneys. The prevalence 
of cardiovascular disorder will tend to increase each year if the 
countermeasures against hypertension are not best performed, A 
report from the Joint National Committee on Hypertension revealed 
that the number of hypertensive patients in the world has reached 1 
million [1]. The incidence of hypertension today has remained a focus 
in developing countries, reaching 37.7%, and is estimated to rise by 
three-quarters of the whole hypertensive population worldwide by 
the year 2025 [2]. Several studies in different countries indicated that 
antihypertensive therapy has proved to be clinically effective for 
countermeasures in hypertension.  
However, many patients do not adhere to the recommended therapy; 
as a result, cases of hypertensive therapy failure frequently occur. It is 
proven by the level of blood pressure that has yet to meet the 
expected target. Based on a study by WHO, the main issue related to 
therapy management for patients with the chronic disease worldwide 
is their adherence to the given medication therapy. This incidence has 
reached a significant point up to 50% and is even likely to rise further 
in developing countries [3]. Uncontrolled hypertension can escalate 
the IHD risk by 3–4 times and become the risk factor of 
cardiovascular incidence by 2-3 times [4]. Even recent case control 
studies showed an increase in the risk of stroke incidence in poorly-
treated hypertensive patients [5].  
Since the enactment of universal coverage in Indonesia in 2014, 
primary health care centers play a major role as the center for 
primary service of public health in Indonesia. Sound, appropriate 
health care in a primary healthcare center is essential as the basis for 
establishing public health financing. In this context, the research was 
conducted on a disease with the highest prevalence in Indonesia, 
which is hypertension, particularly in a primary healthcare setting, by 
focusing on adherence to therapy. The method used to measure 
therapy adherence was MMAS-8 as it has a greater ability [6].  
MATERIALS AND METHODS 
Ethical approval 
This study received approval from the Ethics Committee of the 
Faculty of Medicine, Islamic University of Indonesia and Health 
Service of Special Region Yogyakarta for 8 primary health care. 
Written consent was also obtained from the patients prior to the 
commencement of the study. 
Study setting, design and period  
Indonesia is an archipelago country which consists of 34 province. 
Yogyakarta is the capital of Yogyakarta Special Region province. A 
prospective cross-sectional study was carried out in 8 primary health 
care in Special Region of Yogyakarta spread across the city.  
We investigated the adherence of antihypertensive treatment using 
the eight-item Morisky Medication Adherence Scale (MMAS). The 
MMAS-8 an update with greater sensitivity and the most commonly 
used self-reporting method to determine adherence, contains eight 
questions with closed dichotomous (yes/no) answer, designed to 
prevent the bias of positive responses from patients questions asked 
by health professionals, by reversing the responses related to the 
interviewee’s adherence behavior [7].  
MMAS consists of 8 items with a dichotomous response (yes/no) for 
items 1–7 and a 5 point Likert response for the last item. The total 
score ranges from 0 to 8 with a higher total score indicating higher 
medication adherence. The total score for each patient is the 
summation of the scores in each item. The degree of adherence was 
determined according to the score resulting from the sum of all the 
correct answers: high adherence (eight points), moderate adherence 
(6 to<8 points) and low adherence (<6 points). In this study, patients 
were considered adherent when they had a score equal to eight in the 
MMAS-8. The MMAS showed a good predictive power and was 
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significantly associated with drug pharmacy refill as it showed a 75% 
concordance [8]. 
Study population  
We selected out patients with confirmed diagnosis of hypertension 
who were treated at primary health care, aged 18 or older and who 
used antihypertensive medications. Patients with secondary 
hypertension and compelling indication (Diabetes mellitus, heart 
disease, hyperlipidemia, stroke, and renal failure) confirmed by 
medical records were excluded. This exclusion criterion was aimed to 
eliminate the interference of the cost of drugs, polypharmacy, 
effectivity of the antihypertensive treatment as the major predictive 
factors of nonadherence.  
RESULTS AND DISCUSSION 
A total of 233 patients were eligible for participation in the study and 
eight of whom had been excluded from participating in the study 
(refusal rate = 3, 4 %). In this context, the simplicity of the 8-item 
Morisky Medication Adherence Scale (MMAS-8) as a self-reported 
measure could make it a very practical approach to assess adherence 
to an antihypertensive treatment regimen. Although these methods 
are subject to bias, as the overestimation of adherence, the constant 
improvement of these instruments and their validation studies in 
different populations have increased their adoption in clinical 
practice [6].  
More than 40% patients were not forgetting to take antihypertensive 
medications although they leave the house/travel and having no days 
on which medication was not taken during the previous 2 w 
(56.22%). In contrast, more than 70% of respondents reported that 
they had taken their hypertension medications on the previous day 
and that they had not decided to stop or reduce their hypertension 
medications when they felt worse but more than 49% decided to stop 
their hypertension medications when they felt better. In addition, 
most respondents never (75.97%) or sometimes (12.02%) had 
difficulty remembering their medications. The distributions of 
responses to each item on the 8-item MMAS are shown in table 1. 
 
Table 1: Distribution of responses to items on 8-item MMAS-8 
Item 1–7 Yes (%) No (%) 
1. Do you sometimes forget to take your blood pressure medication?  50.21 49.79 
2. In the last two weeks, was there any day when you did not take your high blood pressure medication?  43.78 56.22 
3. Have you ever stopped taking your medications or decreased the dose without first warning your doctor 
because you felt worse when you took them? 
22.32 77.68 
4.  When you travel or leave the house, do you sometimes forget to take your medications? 42.49 57.51 
5. Did you take your high blood pressure medication yesterday? 73.39 26.61 
6. When you feel your blood pressure is controlled, do you sometimes stop taking your medications? 50.21 49.79 
7. Have you ever felt distressed for strictly following your high blood pressure treatment?  24.46 75.54 
Item 8 Never  Rarely Sometimes Often Always  
8.   How often do you have difficulty in remembering taking all your blood pressure 
medications? 
75.97 9.87 12.02 1.72 0.43 
MMAS, Morisky Medication Adherence Scale 
 
Use of the MMAS is protected by US copyright laws. Permission for 
use is required. A license agreement is available from Donald E. 
Morisky, ScD, ScM, MSPH, Professor, Department of Community 
Health Sciences, UCLA Fielding School of Public Health, 650 Charles E. 
Young Drive South, Los Angeles, CA 90095-1772. 
WHO states that adherence is the extent to which the patient follows 
medical instruction. Adherence also encompasses the numerous health-
related behaviours (diet and/or executing lifestyle changes) that extend 
beyond taking prescribed pharmaceutical with recommendations from 
a health care provider. It estimated that adherence rates range from 
50% to 70%, although the relevant studies varied with respect to study 
population, duration of follow up, and method used to assess adherence 
[3]. Morisky et al. classified adherence into 3 categories: low, 
moderate/medium and high adherence. Patients with high and medium 
adherence were considered adherent. Fig. 1 shown the adherence level 
in each primary health care. The mean percentages of low adherence 
patient were the highest (57.93±11.17). In contrast, the adherence in all 
primary health care lower than 50% that consists of moderate 
adherence (30.25±8.03) and high adherence (11.82±8.18).  
According to literature, poor adherence affects the clinical outcome and 
quality of life, causing risk factor Cardiovascular Diseases (CVD), adverse 
outcomes such as increased morbidity, mortality and healthcare costs. 
Although effective medical therapy and evidence-based treatment 
guidelines for hypertension are readily available, low adherence to 
antihypertensive medications is prevalent, and blood pressure control is 
still not optimal, particularly among older populations [9]. 
 
 
Fig. 1: Adherence level of hypertension treatment in primary health care (PHC) 
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Sociodemographic characteristics and life habits of hypertensive 
patients in every adherence level are shown in table 2. Minimum age 
of the patients was 32 y and the majority were 60–69 y (42.6%) with 
64% of them were females. Only 46.3% patients practiced some 
regular physical activity. Smoking was reported by 15.45% of 
patients. Antihypertensive monotherapy were prescribed to 79.40% 
of patients, such as amlodipine, captopril, and HCT while 29.60% 
patients using combination amlodipine and hydrochlorothiazide. 
  
Table 2: Sociodemographic and life habits of hypertensive outpatients 
Variable Low adherence  Medium adherence  High adherence  
n (%) n (%) n (%) 
Age             
30-39 2 100     
40-49 14 53.85 9 34.62 3 11.54 
50-59 36 69.23 11 21.15 5 9.62 
60-69 54 55.10 37 37.76 7 7.14 
70 or older  37 67.27 12 21.82 6 10.91 
Gender        
Female  90 60 42 28 18 12 
Male  50 60.24 28 33.73 5 6.02 
Antihypertensive drugs       
Monotherapy 107 57.84 61 32.97 17 9.19 
Double therapy  33 68.75 9 18.75 6 12.50 
Level of schooling       
Illiterate 41 100     
Elementary school 21 32.31 33 50.77 11 16.92 
Junior High school 32 68.09 14 29.79 1 2.13 
High school 27 52.94 16 31.37 8 15.69 
College/University 19 65.52 7 24.14 3  10.34 
Physical Activity       
Yes 62 57.41 36 33.33 10 9.26 
No 68 54.40 34 27.20 23 18.40 
Smoker       
Yes 16 44.44 12 33.33 8 22.22 
No 114 57.87 63 31.98 20 10.15 
 
Among patients with lower adherence 76.43% (45.92% of total 
patients) using monotherapy. According to two major studies 
reviewing therapeutic adherence, one of which covers fifty years of 
research on the topic, adherence has no apparent association with the 
demographic characteristics-such as gender, age, socioeconomic 
status and ethnic group and disease severity [10, 11]. Some 
predictors, however, have been consistently associated with poor 
adherence, among which we highlight the complexity of the regimen, 
the treatment of asymptomatic disease, the presence of psychological 
problems like depression and medication side effects [12, 13]. 
Limitation of the Study 
We evaluated the treatment adherence of hypertension in primary 
health care but it didn’t correlate with blood pressure target directly, 
sociodemographic and life habits of the patients. We only described 
the adherence level of the antihypertensive treatment. 
CONCLUSION 
In conclusion, we found that poor adherence was high. The average 
adherence value according to the MMAS-8 was 5.2 (±1.7). Findings 
from this research we suggest that pharmacist have a great role to 
support the adherence therapy. Future studies are recommended to 
confirm our findings, as adherence to medication predicts better 
outcomes and indicators of poor adherence to a medication regimen 
are a useful resource for physicians to help identify patients who are 
most in need of interventions to improve adherence.  
 We also recommend the implementation of education campaigns to 
increase awareness about the risk factors, natural history, 
complications and treatment of hypertension. Global events, such as 
World Hypertension Day, could be used as a forum to highlight these 
issues. Patient support groups can be employed to help the non-
adherent. Patients who have suffered complications due to non-
adherence could be requested to voluntarily share their experiences. 
Print and audiovisual media would be very helpful in the 
dissemination of information. Most importantly, though, physicians 
have to pay special attention to patient education and counselling. 
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